A chronic disease management model for chronic liver failure is cost-effective; cost-effectiveness analysis

2017 ◽  
Vol 66 (1) ◽  
pp. S121
Author(s):  
A.J. Wigg ◽  
J.K. Chin ◽  
B. Kaambwa
Hepatology ◽  
2014 ◽  
Vol 61 (2) ◽  
pp. 725-728 ◽  
Author(s):  
Alan J. Wigg ◽  
Mohamed A. Chinnaratha ◽  
Rachel Wundke ◽  
Michael L. Volk

2013 ◽  
Vol 11 (7) ◽  
pp. 850-858.e4 ◽  
Author(s):  
Alan J. Wigg ◽  
Rosemary McCormick ◽  
Rachel Wundke ◽  
Richard J. Woodman

2018 ◽  
Vol 33 (9) ◽  
pp. 1634-1640 ◽  
Author(s):  
Alan J Wigg ◽  
Jong K Chin ◽  
Kate R Muller ◽  
Jeyamani Ramachandran ◽  
Richard J Woodman ◽  
...  

2010 ◽  
Vol 34 (2) ◽  
pp. 162 ◽  
Author(s):  
Derek P. Chew ◽  
Robert Carter ◽  
Bree Rankin ◽  
Andrew Boyden ◽  
Helen Egan

Background.The cost effectiveness of a general practice-based program for managing coronary heart disease (CHD) patients in Australia remains uncertain. We have explored this through an economic model. Methods.A secondary prevention program based on initial clinical assessment and 3 monthly review, optimising of pharmacotherapies and lifestyle modification, supported by a disease registry and financial incentives for quality of care and outcomes achieved was assessed in terms of incremental cost effectiveness ratio (ICER), in Australian dollars per disability adjusted life year (DALY) prevented. Results.Based on 2006 estimates, 263 487 DALYs were attributable to CHD in Australia. The proposed program would add $115 650 000 to the annual national heath expenditure. Using an estimated 15% reduction in death and disability and a 40% estimated program uptake, the program’s ICER is $8081 per DALY prevented. With more conservative estimates of effectiveness and uptake, estimates of up to $38 316 per DALY are observed in sensitivity analysis. Conclusions.Although innovation in CHD management promises improved future patient outcomes, many therapies and strategies proven to reduce morbidity and mortality are available today. A general practice-based program for the optimal application of current therapies is likely to be cost-effective and provide substantial and sustainable benefits to the Australian community. What is known about this topic?Chronic disease management programs are known to provide gains with respect to reductions in death and disability among patients with coronary heart disease. The cost effectiveness of such programs in the Australian context is not known. What does this paper add?This paper suggests that implementing a coronary heart disease program in Australia is highly cost-effective across a broad range of assumptions of uptake and effectiveness. What are the implications for practitioners? These data provide the economic rationale for the implementation of a chronic disease management program with a disease registry and regular review in Australia.


BMJ Open ◽  
2019 ◽  
Vol 9 (12) ◽  
pp. e030301 ◽  
Author(s):  
Andrew P Costa ◽  
Connie Schumacher ◽  
Aaron Jones ◽  
Darly Dash ◽  
Graham Campbell ◽  
...  

IntroductionHome care clients are increasingly medically complex, have limited access to effective chronic disease management and have very high emergency department (ED) visitation rates. There is a need for more appropriate and targeted supportive chronic disease management for home care clients. We aim to evaluate the effectiveness and preliminary cost effectiveness of a targeted, person-centred cardiorespiratory management model.Methods and analysisThe Detection of Indicators and Vulnerabilities of Emergency Room Trips (DIVERT) — Collaboration Action Research and Evaluation (CARE) trial is a pragmatic, cluster-randomised, multicentre superiority trial of a flexible multicomponent cardiorespiratory management model based on the best practice guidelines. The trial will be conducted in partnership with three regional, public-sector, home care providers across Canada. The primary outcome of the trial is the difference in time to first unplanned ED visit (hazard rate) within 6 months. Additional secondary outcomes are to identify changes in patient activation, changes in cardiorespiratory symptom frequencies and cost effectiveness over 6 months. We will also investigate the difference in the number of unplanned ED visits, number of inpatient hospitalisations and changes in health-related quality of life. Multilevel proportional hazard and generalised linear models will be used to test the primary and secondary hypotheses. Sample size simulations indicate that enrolling 1100 home care clients across 36 clusters (home care caseloads) will yield a power of 81% given an HR of 0.75.Ethics and disseminationEthics approval was obtained from the Hamilton Integrated Research Ethics Board as well as each participating site’s ethics board. Results will be submitted for publication in peer-reviewed journals and for presentation at relevant conferences. Home care service partners will also be informed of the study’s results. The results will be used to inform future support strategies for older adults receiving home care services.Trial registration numberNCT03012256.


Curationis ◽  
2017 ◽  
Vol 40 (1) ◽  
Author(s):  
Ozayr H. Mahomed ◽  
Shaidah Asmall

Background: An integrated chronic disease management model has been implemented across primary healthcare clinics in order to transform the delivery of services for patients with chronic diseases. The sustainability and rapid scale-up of the model is dependent on positive staff perceptions and experiences.Objectives: The aim of the study was to determine the perceptions and experiences of professional nurses with the integrated chronic care model that has been implemented.Method: A cross-sectional descriptive survey utilising a self-administered questionnaire was conducted amongst all professional nurses who were involved in delivering primary healthcare services at the 42 implementing facilities in September 2014. Each facility has between four and eight professional nurses providing a service daily at the facilitiesResults: A total of 264 professional nurses participated in the survey. Prior to the implementation, 34% (91) of the staff perceived the model to be an added programme, whilst 36% (96) of the staff experienced an increased workload. Staff noted an improved process of care, better level of interaction with patients, improved level of knowledge and better teamwork coupled with an improved level of satisfaction with the work environment at the clinic after implementation of the integrated chronic disease model.Conclusion: Professional nurses have a positive experience with the implementation of the integrated chronic disease management model.


PLoS ONE ◽  
2020 ◽  
Vol 15 (6) ◽  
pp. e0235429
Author(s):  
Limakatso Lebina ◽  
Mary Kawonga ◽  
Tolu Oni ◽  
Hae-Young Kim ◽  
Olufunke A. Alaba

Sign in / Sign up

Export Citation Format

Share Document